Crossref
Correlation of Serum Myeloperoxidase and Paraoxonase 1 Levels with Atherosclerotic Risk in Metabolic Syndrome
International Journal of Pharmaceutical Quality Assurance · 11.07.2026 · 16 (12)
DOI: 10.25258/ijpqa.16.12.61 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 11.07.2026. Verfasst von Ivy Ray und 2 weiteren Autor:innen.
Abstract (Originalsprache)
.
Zitieren
APA
Ray, I., Ray, B., & M., D. (2026). Correlation of Serum Myeloperoxidase and Paraoxonase 1 Levels with Atherosclerotic Risk in Metabolic Syndrome. International Journal of Pharmaceutical Quality Assurance, 16(12). https://doi.org/10.25258/ijpqa.16.12.61
Vancouver
Ray I, Ray B, M. D. Correlation of Serum Myeloperoxidase and Paraoxonase 1 Levels with Atherosclerotic Risk in Metabolic Syndrome. International Journal of Pharmaceutical Quality Assurance. 2026;16(12). doi:10.25258/ijpqa.16.12.61
BibTeX
@article{Ray2026,
author = {Ray, Ivy and Ray, Binay and M., Divya},
title = {Correlation of Serum Myeloperoxidase and Paraoxonase 1 Levels with Atherosclerotic Risk in Metabolic Syndrome},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {16},
number = {12},
doi = {10.25258/ijpqa.16.12.61}
}
EUVIMED